# A Study to Test the Effects and Safety of Palopegteriparatide in Adolescents With Long-term Hypoparathyroidism

> **NCT07706764** · PHASE3 · RECRUITING · sponsor: **Ascendis Pharma A/S** · enrollment: 12 (estimated)

## Conditions studied

- Hypoparathyroidism

## Interventions

- **COMBINATION_PRODUCT:** Palopegteriparatide

## Key facts

- **NCT ID:** NCT07706764
- **Lead sponsor:** Ascendis Pharma A/S
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04-22
- **Primary completion:** 2027-08
- **Final completion:** 2031-08
- **Target enrollment:** 12 (ESTIMATED)
- **Last updated:** 2026-07-28


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07706764

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07706764, "A Study to Test the Effects and Safety of Palopegteriparatide in Adolescents With Long-term Hypoparathyroidism". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07706764. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*